Membrane transport proteins in human melanoma: associations with tumour aggressiveness and metastasis-Reference-Cited by-同舟云学术

Membrane transport proteins in human melanoma: associations with tumour aggressiveness and metastasis

Published:2010-03 Issue:7 Volume:102 Page:1157-1162
ISSN:0007-0920
Container-title:British Journal of Cancer
language:en
Short-container-title:Br J Cancer

Author:

Walsh N,Kennedy S,Larkin A M,Tryfonopoulos D,Eustace A J,Mahgoub T,Conway C,Oglesby I,Collins D,Ballot J,Ooi W S,Gullo G,Clynes M,Crown J,O'Driscoll L

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Oncology

Link

http://www.nature.com/articles/6605590.pdf

Reference21 articles.

1. Agarwala SS (2009) Current systemic therapy for metastatic melanoma. Expert Rev Anticancer Ther 9: 587–595

2. Berger W, Hauptmann E, Elbling L, Vetterlein M, Kokoschka EM, Micksche M (1997) Possible role of the multidrug resistance-associated protein (MRP) in chemoresistance of human melanoma cells. Int J Cancer 71: 108–115

3. Bhatia S, Tykodi SS, Thompson JA (2009) Treatment of metastatic melanoma: an overview. Oncology (Williston Park) 23: 488–496

4. Colone M, Calcabrini A, Toccacieli L, Bozzuto G, Stringaro A, Gentile M, Cianfriglia M, Ciervo A, Caraglia M, Budillon A, Meo G, Arancia G, Molinari A (2008) The multidrug transporter P-glycoprotein: a mediator of melanoma invasion? J Invest Dermatol 128: 957–971

5. Connolly L, Moran E, Larkin A, Scheffer G, Scheper R, Sarkadi B, Kool M, Clynes M (2001) A new monoclonal antibody, P2A8(6), that specifically recognizes a novel epitope on the multidrug resistance-associated protein 1 (MRP1), but not on MRP2 nor MRP3. Hybrid Hybridomics 20: 333–341

Cited by 32 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Evaluation of ABT-751, a novel anti-mitotic agent able to overcome multi-drug resistance, in melanoma cells;Cancer Chemotherapy and Pharmacology;2024-01-16

2. BCRP drives intrinsic chemoresistance in chemotherapy-naïve breast cancer brain metastasis;Science Advances;2023-10-20

3. ABCC1 and glutathione metabolism limit the efficacy of BCL-2 inhibitors in acute myeloid leukemia;Nature Communications;2023-09-19

4. Programmed-response cross-linked nanocarrier for multidrug-resistant ovarian cancer treatment;Journal of Controlled Release;2023-05

5. A macrocyclic peptide inhibitor traps MRP1 in a catalytically incompetent conformation;Proceedings of the National Academy of Sciences;2023-03-09